An intervention to prevent symptoms associated with hepatitis C: a pilot study

References 

1. American College of Sports Medicine . Physical activity and public health guidelines. Last viewed February 18, 2008 at http://www.acsm.org/AM/Template.cfm?Section=Home_Page&TEMPLATE=CM/HTMLDisplay.cfm&CONTENTID=77642007;
2. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine. 2006;144:705–714
3. Bayliss MS, Gandek B, Bungay KM, Sugano D, Hsu MA, Ware JE. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Quality of Life Research. 1998;7:39–55
4. Centers for Disease Control and Prevention . Physical activity for everyone: Recommendations. Last viewed February 18, 2008, at http://www.cdc.gov/nccdphp/dnpa/physical/recomendations/index.htm2007;
5. Chopra S. The liver book. New York: Simon and Schuster, Inc.; 2001;
6. Clark CH, Mahoney JS, Clark DJ, Erikson LR. Screening for depression in a hepatitis C population: The reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D). Journal of Advanced Nursing. 2002;40(3):361–369
   • MEDLINE
   • CrossRef
7. Cooper KH. A means of assessing maximal oxygen uptake. Journal of the American Medical Association. 1968;203:201–204
8. Cotler SJ, Wartelle CF, Larson AM, Gretch DR, Jensen DM, Carrithers RL. Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. Journal of Viral Hepatitis. 2000;7(3):211–217
   • MEDLINE
   • CrossRef
9. Gapinski, M. A., Zucker, D. M. (2005). Factors influencing the development of an hepatitis C exercise protocol: A literature review. Gastroenterology Nursing, 28(3) S10–18; S31–3.
10. Gish R. Hepatitis C: Current standards of care and future perspectives. HCV Advocate. www.hcvadvocate.org/hcsp/hcsp_pdf/Current_Standards_2006.pdf2006;
11. Goh J, Coughlan B, Quinn J, O'Keane JC, Crowe J. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. European Journal of Gastroenterology and Hepatology. 1999;11(8):833–838
12. Heitkemper M, Jarrett M, Kurashige EM, Carithers R. Chronic hepatitis C: Implications for health-related quality of life. Gastroenterology Nursing. 2001;24(4):169–177
13. Hendelman D, Miller K, Baggett C, Debold E, Freedson P. Validity of accelerometry for the assessment of moderate intensity physical activity in the field. Medicine and Science in Sports and Exercise. 2000;32(9):S442–S449
    • MEDLINE
    • CrossRef
14. Mock V, Barton-Burke M, Sheehan P, Creaton EM, Winningham ML, McKenney-Tedder S, et al. A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherapy. Oncology Nursing Forum. 1994;21(5):899–908
    • MEDLINE
15. Mock V, Dow KH, Meares CJ, Grimm PM, Dienemann JA, Haisfield-Wolf ME, et al. Effects of exercise on fatigue, physical functioning and emotional distress during radiation therapy for breast cancer. Oncology Nursing Forum. 1997;24(6):991–1000
    • MEDLINE
16. Schwartz AL. Patterns of exercise and fatigue in physically active cancer survivors. Oncology Nursing Forum. 1998;25(3):485–491
    • MEDLINE
17. Schwartz AL. Reliability and validity of the Schwartz Cancer Fatigue Scale. Oncology Nursing Forum. 1998;25(4):711–717
    • MEDLINE
18. Schwartz AL, Thompson JA, Masood N. Interferon-induced fatigue in patients with melanoma: A pilot study of excise and methyphenidate. Oncology Nursing Forum. 2002;29(7):E85–E90
19. Seeff LB. The natural history of hepatitis C. American Journal of Medicine. 1999;107:10S–15S
20. Ware JE, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response. The Interventional Group. Hepatology. 1999;30(2):550–555